No major side effects of HCQ, should be continued as preventive treatment for Covid 19 : ICMR
The Indian Council of Medical Research (ICMR) has once again said recently that no significant side effects of the anti-malarial drug Hydroxychloroquine (HCQ) found in the studies made in India. It has suggested the continued use of HCQ as a preventive treatment for the coronavirus.
ICMR's statement has become a subject of discussion against the World Health Organization's backdrop, which has paused hydroxychloroquine trials citing safety concerns.
Balram Bhargava, the Director-General of ICMR in a press meet has shared how this HCQ drug works positively in exceptional cases.
Watch the video for more insight.